Furthermore, considering the syntaxin-6 risk effect was identified for sCJD, such an effect may not be sufficient to substantially modulate incubation times in a prion-infection paradigm using 1% infected brain homogenate with the high infectious prion dose administered being substantially different from a disease-initiating event in sporadic disease. This evidence concerns the gene STX6 and infection.